75T-10844-37023
4 vaccinations
7 coded responses
27 check-ins
7 free-text entries
7 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 277 / NC
- Registered
- 2021-02-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-08
Dose 1 — Pfizer-BioNTech
-
2021-02-09
Registered in v-safe
- 2021-02-09
- 2021-02-10
- 2021-02-11
-
2021-02-12
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-22
-
2021-03-01
Survey response — day 21, dose 1MedDRA: Rash, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: I developed a rash early last week that worsened considerably by Thursday. My immunologist had me skip a weekly infusion on Thursday and recommended not getting 2nd vaccine on 2/27. Just saw dermatologist. Rash is allergic in nature. · Healthcare visit (other): DermatologistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-01
Report sent to call center — day 21, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-08
-
2021-03-10
Dose 2 — Pfizer-BioNTech
-
2021-03-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-16
- 2021-03-17
- 2021-03-31
-
2021-04-07
Survey response — day 28, dose 2MedDRA: Fatigue, Laboratory test, Nausea, Staphylococcal infection — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Nausea-fatigue NOT vaccine related. Have MRSA infection relapse. · Healthcare visit (other): Lab testsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Report sent to call center — day 28, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-14
Survey response — day 35, dose 2MedDRA: Staphylococcal infection — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fighting MRSA infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Report sent to call center — day 35, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-21
Survey response — day 42, dose 2MedDRA: Diarrhoea, Unevaluable event, Vomiting — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Symptoms: Dehydration diarrhea and vomiting Am no hospitalized. · Healthcare visit (other): All post 4 weeks of Linezolid for MRSA Recurrence.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-21
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-09
Survey response — 3 months, dose 2MedDRA: Staphylococcal infection — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Got MRSA infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-09
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-28
- 2021-07-02
-
2021-08-22
Dose 3 — Pfizer-BioNTech
-
2021-10-02
Survey response — day 35, dose 3MedDRA: Drug hypersensitivity, Hospitalisation, Pneumonia, Septic shock, Staphylococcal infection — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Hospital stay septic shock, pneumonia, severe antibiotic allergic reaction, MRSA infection.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Report sent to call center — day 35, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2021-10-03
- 2021-10-04
- 2021-11-21
-
2022-02-22
Survey response — 6 months, dose 3MedDRA: Granuloma, Interstitial lung disease, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Diagnosed with Granulomatous and Lymphocytic Interstitial Lung Diseases (GLILD) i · Healthcare visit (other): Outpatient surgical biopsiesMedDRA releases: 2024-11 · check-in free text available
-
2022-02-22
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-24
-
2022-07-22
Dose 4 — Pfizer-BioNTech
- 2022-08-22
- 2022-08-22
- 2022-08-28
- 2022-09-02
- 2023-01-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-08 | Pfizer-BioNTech | |
| 2 | 2021-03-10 | Pfizer-BioNTech | |
| 3 | 2021-08-22 | Pfizer-BioNTech | No |
| 4 | 2022-07-22 | Pfizer-BioNTech | No |
Call center
7 call center cases
7 unsuccessful
Free text
Release 4 — day 21, dose 1
Symptoms: I developed a rash early last week that worsened considerably by Thursday. My immunologist had me skip a weekly infusion on Thursday and recommended not getting 2nd vaccine on 2/27. Just saw dermatologist. Rash is allergic in nature.
Healthcare visit (other): Dermatologist
Release 7 — day 28, dose 2
Symptoms: Nausea-fatigue NOT vaccine related. Have MRSA infection relapse.
Healthcare visit (other): Lab tests
Release 7 — day 35, dose 2
Symptoms: Fighting MRSA infection
Release 7 — day 42, dose 2
Symptoms: Dehydration diarrhea and vomiting Am no hospitalized.
Healthcare visit (other): All post 4 weeks of Linezolid for MRSA Recurrence.
Release 9 — 3 months, dose 2
Symptoms: Got MRSA infection
Release 9 — day 35, dose 3
Symptoms: Hospital stay septic shock, pneumonia, severe antibiotic allergic reaction, MRSA infection.
Release 11 — 6 months, dose 3
Symptoms: Diagnosed with Granulomatous and Lymphocytic Interstitial Lung Diseases (GLILD) i
Healthcare visit (other): Outpatient surgical biopsies
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Laboratory test | ✓ | ✓ | ✓ |
| HCVO | Office visit | · | · | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Drug hypersensitivity | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Granuloma | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Interstitial lung disease | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Septic shock | · | · | ✓ |
| SD | Staphylococcal infection | ✓ | ✓ | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release